These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8538048)

  • 1. [Muir-Torre syndrome].
    Yoshikawa R; Utsunomiya J
    Nihon Rinsho; 1995 Nov; 53(11):2803-6. PubMed ID: 8538048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muir-Torre syndrome.
    Cohen PR; Kohn SR; Davis DA; Kurzrock R
    Dermatol Clin; 1995 Jan; 13(1):79-89. PubMed ID: 7712655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
    Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M
    Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite instability in Muir-Torre syndrome.
    Honchel R; Halling KC; Schaid DJ; Pittelkow M; Thibodeau SN
    Cancer Res; 1994 Mar; 54(5):1159-63. PubMed ID: 8118799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas.
    Ponti G; Losi L; Pedroni M; Lucci-Cordisco E; Di Gregorio C; Pellacani G; Seidenari S
    J Invest Dermatol; 2006 Oct; 126(10):2302-7. PubMed ID: 16826164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Muir-Torre syndrome and familial colorectal cancer: 2 families with molecular genetic analysis].
    Doré MX; Dieumegard B; Grandjouan S; Avril MF; Martinet C; Ducreux M; Lasser P; Bressac-de Paillerets B
    Ann Dermatol Venereol; 1999; 126(8-9):582-6. PubMed ID: 10530344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mutation in the MSH2 gene in Muir-Torre syndrome].
    Godard V; Coulet F; Bernaudin JF; Housset M; Soubrier F
    Ann Dermatol Venereol; 1999; 126(8-9):600-3. PubMed ID: 10530347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Torre-Muir syndrome. Sebaceous gland tumors indicate colon carcinoma and other internal malignant tumors].
    Karsten U; Christophers E; Sterry W
    Dtsch Med Wochenschr; 1987 Aug; 112(34):1296-301. PubMed ID: 3622267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muir-Torre syndrome: a rare but important disorder.
    Hare HH; Mahendraker N; Sarwate S; Tangella K
    Cutis; 2008 Oct; 82(4):252-6. PubMed ID: 19055168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sebaceous skin lesions as clues to hereditary non-polyposis colorectal cancer.
    Lynch HT; Fusaro RM; Lynch PM
    J Invest Dermatol; 2006 Oct; 126(10):2158-9. PubMed ID: 16983324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solitary subungual keratoacanthoma arising in an MSH2 germline mutation carrier: confirmation of a relationship by immunohistochemical analysis.
    Stoebner PE; Fabre C; Delfour C; Joujoux JM; Roger P; Dandurand M; Meunier L
    Dermatology; 2009; 219(2):174-8. PubMed ID: 19602866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muir-torre syndrome with intriguing squamous lesions: a case report and review of the literature.
    Nishizawa A; Nakanishi Y; Sasajima Y; Yamazaki N; Yamamoto A
    Am J Dermatopathol; 2006 Feb; 28(1):56-9. PubMed ID: 16456327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Torre-Muir syndrome. Sebaceous gland neoplasms, keratoacanthomas, multiple internal cancers and heredity].
    Worret WI; Burgdorf WH; Fahmy A; Pitha J
    Hautarzt; 1981 Oct; 32(10):519-24. PubMed ID: 7298331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different phenotypes in Muir-Torre syndrome: clinical and biomolecular characterization in two Italian families.
    Ponti G; Ponz de Leon M; Losi L; Di Gregorio C; Benatti P; Pedroni M; Scarselli A; Riegler G; Lembo L; Pellacani G; Seidenari S; Rossi G; Roncucci L
    Br J Dermatol; 2005 Jun; 152(6):1335-8. PubMed ID: 15949004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muir-Torre syndrome: a case report and review of the literature.
    Pettey AA; Walsh JS
    Cutis; 2005 Mar; 75(3):149-55. PubMed ID: 15839358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors].
    Mercader P; García-Melgares ML; Roche E; Sánchez-Carazo JL; Alegre-de Miquel V
    Actas Dermosifiliogr; 2008 Sep; 99(7):532-9. PubMed ID: 18682166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.
    Abbas O; Mahalingam M
    J Cutan Pathol; 2009 Jun; 36(6):613-9. PubMed ID: 19515040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Muir-Torre syndrome family.
    Serleth HJ; Kisken WA
    Am Surg; 1998 Apr; 64(4):365-9. PubMed ID: 9544152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muir-Torre syndrome.
    Ponti G; Ponz de Leon M
    Lancet Oncol; 2005 Dec; 6(12):980-7. PubMed ID: 16321766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All patients with sebaceous gland neoplasms should be screened for Muir-Torre syndrome.
    Ingram JR; Griffiths AP; Roberts DL
    Clin Exp Dermatol; 2009 Mar; 34(2):264-6. PubMed ID: 19187311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.